Literature DB >> 20511441

Osteofibrous dysplasia and adamantinoma.

Mathew J Most1, Franklin H Sim, Carrie Y Inwards.   

Abstract

Osteofibrous dysplasia (OFD) is a rare, benign, fibro-osseous lesion that typically is seen within the cortex of the tibia in children. Adamantinoma (AD) is a rare, low-grade malignant primary bone tumor that occurs most often in the tibia and/or fibula of adolescent persons and young adults; however, it has been reported in other long bones, as well. Immunohistochemical and ultrastructural evidence has shown that the neoplastic cell in AD derives from an epithelial lineage. More recently, published reports have described another clinical entity-differentiated or OFD-like AD-that appears to lie between OFD and AD along a spectrum of disease. Controversy exists as to whether OFD is a precursor lesion to AD or whether OFD may be a residual lesion resulting from a spontaneously regressing AD. Management of OFD varies from observation to surgical intervention, depending on the age of the patient and the extent of the lesion. Management of AD requires surgical resection with wide margins, followed by appropriate reconstruction, to minimize the risk of local recurrence or metastasis.

Entities:  

Mesh:

Year:  2010        PMID: 20511441     DOI: 10.5435/00124635-201006000-00008

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  11 in total

1.  Adamantinoma of the tibia and fibula with pulmonary metastasis: an unusual presentation.

Authors:  Chékib Khémiri; Dalila Mrabet; Habiba Mizouni; Imen Abbes; Emna Mnif; Slaheddine Sellami; Hamza Essaddem
Journal:  BMJ Case Rep       Date:  2011-10-16

2.  Osteofibrous dysplasia-like adamantinoma of isolated fibula in a child mimicking chronic osteomyelitis with pathological fracture.

Authors:  Pierre-Emmanuel Goetz; Dana Dumitriu; Christine Galant; Pierre-Louis Docquier
Journal:  J Surg Case Rep       Date:  2022-06-07

3.  Fibula-Assisted Segment Transport (FAST) for Defect Reconstruction after Resection of Tibial Adamantinoma: Report of Two Treatments.

Authors:  A Rachbauer; A Laufer; G Gosheger; G Toporowski; A Frommer; E Jacob; N Deventer; R Roedl; B Vogt
Journal:  Case Rep Orthop       Date:  2021-05-01

4.  Osteofibrous dysplasia of clavicle clinically mimicking chronic osteomyelitis.

Authors:  Nirmal Raj Gopinathan; Mahesh Prakash; Balaji Saibaba; Ashim Das
Journal:  Indian J Radiol Imaging       Date:  2016 Apr-Jun

5.  Epidemiological Study of Adamantinoma from US Surveillance, Epidemiology, and End Results Program: III Retrospective Analysis.

Authors:  Mahmut Nedim Aytekin; Recep Öztürk; Kamil Amer
Journal:  J Oncol       Date:  2020-06-16       Impact factor: 4.375

6.  Osteofibrous dysplasia arising in the humerus: A case report.

Authors:  Shinichirou Yoshida; Munenori Watanuki; Kouu Hayashi; Masami Hosaka; Yoshihiro Hagiwara; Eiji Itoi; Masahito Hatori; Shin Hitachi; Mika Watanabe
Journal:  Rare Tumors       Date:  2018-11-05

7.  Clonality assessment in a case of multifocal adamantinoma and a review of the literature.

Authors:  Paul Borbas; Andreas Leithner; Patrick Sadoghi; Anne Berndt; Bernadette Liegl; Oskar A Haas
Journal:  Case Rep Med       Date:  2012-10-09

8.  Osteofibrous Dysplasia managed with Extraperiosteal excision, Autologous free fibular graft and bone graft substitute.

Authors:  Vineet T Abraham; Chandrasekaran Marimuthu; Ravichandran Subbaraj; Nandakumar Rengarajan
Journal:  J Orthop Case Rep       Date:  2015 Jan-Mar

9.  Long-Term Follow-Up of Adamantinoma of the Tibia Complicated by Metastases and a Second Unrelated Primary Cancer: A Case Report and Literature Review.

Authors:  Brendan R Southam; Alvin H Crawford; David A Billmire; James Geller; Daniel Von Allmen; Adam P Schumaier; Sara Szabo
Journal:  Case Rep Orthop       Date:  2018-03-25

10.  Osteofibrous dysplasia-like adamantinoma treated via intercalary segmental resection with partial cortex preservation using pedicled vascularized fibula graft: a case report.

Authors:  Yuji Yamamura; Makoto Emori; Nobuyuki Takahashi; Mitsumasa Chiba; Junya Shimizu; Yasutaka Murahashi; Shintaro Sugita; Kousuke Iba; Tadashi Hasegawa; Toshihiko Yamashita
Journal:  World J Surg Oncol       Date:  2020-08-13       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.